Rockwell Medical Statistics
Total Valuation
RMTI has a market cap or net worth of $34.47 million. The enterprise value is $23.53 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RMTI has 39.41 million shares outstanding. The number of shares has increased by 14.40% in one year.
| Current Share Class | 39.41M |
| Shares Outstanding | 39.41M |
| Shares Change (YoY) | +14.40% |
| Shares Change (QoQ) | +4.99% |
| Owned by Insiders (%) | 1.39% |
| Owned by Institutions (%) | 8.62% |
| Float | 33.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.39 |
| Forward PS | 0.46 |
| PB Ratio | 0.92 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.35.
| Current Ratio | 3.92 |
| Quick Ratio | 3.34 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.27 |
Financial Efficiency
Return on equity (ROE) is -16.68% and return on invested capital (ROIC) is -6.44%.
| Return on Equity (ROE) | -16.68% |
| Return on Assets (ROA) | -5.25% |
| Return on Invested Capital (ROIC) | -6.44% |
| Return on Capital Employed (ROCE) | -10.05% |
| Revenue Per Employee | $309,742 |
| Profits Per Employee | -$24,307 |
| Employee Count | 244 |
| Asset Turnover | 1.32 |
| Inventory Turnover | 13.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.42% in the last 52 weeks. The beta is 1.61, so RMTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -62.42% |
| 50-Day Moving Average | 1.20 |
| 200-Day Moving Average | 1.22 |
| Relative Strength Index (RSI) | 30.59 |
| Average Volume (20 Days) | 411,692 |
Short Selling Information
The latest short interest is 1.03 million, so 2.62% of the outstanding shares have been sold short.
| Short Interest | 1.03M |
| Short Previous Month | 1.08M |
| Short % of Shares Out | 2.62% |
| Short % of Float | 3.12% |
| Short Ratio (days to cover) | 1.90 |
Income Statement
In the last 12 months, RMTI had revenue of $75.58 million and -$5.93 million in losses. Loss per share was -$0.17.
| Revenue | 75.58M |
| Gross Profit | 11.45M |
| Operating Income | -4.81M |
| Pretax Income | -5.52M |
| Net Income | -5.93M |
| EBITDA | -2.62M |
| EBIT | -4.81M |
| Loss Per Share | -$0.17 |
Full Income Statement Balance Sheet
The company has $23.71 million in cash and $13.13 million in debt, giving a net cash position of $10.58 million or $0.27 per share.
| Cash & Cash Equivalents | 23.71M |
| Total Debt | 13.13M |
| Net Cash | 10.58M |
| Net Cash Per Share | $0.27 |
| Equity (Book Value) | 37.02M |
| Book Value Per Share | 0.94 |
| Working Capital | 27.93M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$2.09 million and capital expenditures -$851,000, giving a free cash flow of -$2.94 million.
| Operating Cash Flow | -2.09M |
| Capital Expenditures | -851,000 |
| Free Cash Flow | -2.94M |
| FCF Per Share | -$0.07 |
Full Cash Flow Statement Margins
Gross margin is 15.15%, with operating and profit margins of -6.37% and -7.30%.
| Gross Margin | 15.15% |
| Operating Margin | -6.37% |
| Pretax Margin | -7.30% |
| Profit Margin | -7.30% |
| EBITDA Margin | -3.47% |
| EBIT Margin | -6.37% |
| FCF Margin | n/a |
Dividends & Yields
RMTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.40% |
| Shareholder Yield | -14.40% |
| Earnings Yield | -17.39% |
| FCF Yield | -8.61% |
Analyst Forecast
The average price target for RMTI is $3.75, which is 328.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.75 |
| Price Target Difference | 328.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 13, 2022. It was a reverse split with a ratio of 1:11.
| Last Split Date | May 13, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:11 |
Scores
RMTI has an Altman Z-Score of -6.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.51 |
| Piotroski F-Score | 2 |